Bottom line: SVFC has about a 1.2 million market valuation with a mere 5-7 million in pertinent debt. The debt is small for biotech type stock. Stem cell peers are trading 50-150 mil valuations.
And SVFC has the patented, leading stem cell extraction method with numerous advantages. Working on a lucrative IND with Dr. James Andrews and Inventiv. 2 pretty significant players...
SVFC traded over 60 mil valuation less than 2 yrs ago..
This could run 20x and still be undervalued.....
The market potential of a simple and highly effective OA stem cell treatment is beyond numbers..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.